158 related articles for article (PubMed ID: 6803702)
1. [Importance of pharmacokinetic studies in the clinical phase of experimentation with anti-arrhythmia agents].
Jaillon P
Arch Mal Coeur Vaiss; 1981 Dec; 74 Spec No():57-64. PubMed ID: 6803702
[No Abstract] [Full Text] [Related]
2. Clinical application of pharmacokinetics for antiarrhythmic drugs.
Harrison DC
Arch Mal Coeur Vaiss; 1981 Dec; 74 Spec No():65-72. PubMed ID: 6803703
[TBL] [Abstract][Full Text] [Related]
3. Drug therapy of cardiac arrhythmias.
Heger JJ; Prystowsky EN; Zipes DP
Cardiol Clin; 1983 May; 1(2):305-22. PubMed ID: 6443562
[TBL] [Abstract][Full Text] [Related]
4. [Epidemiology and experimentation of anti-arrhythmia drugs].
Latini R; Maggioni A; Tognoni G; Volpi A
Recenti Prog Med; 1986; 77(7-8):380-9. PubMed ID: 3538252
[No Abstract] [Full Text] [Related]
5. [Therapy of arrhythmias. New anti-arrhythmia agents].
Scholz H
Verh Dtsch Ges Herz Kreislaufforsch; 1981; 47():18-33. PubMed ID: 6173967
[No Abstract] [Full Text] [Related]
6. Tocainide for arrhythmias.
Med Lett Drugs Ther; 1985 Feb; 27(680):9-11. PubMed ID: 3918240
[No Abstract] [Full Text] [Related]
7. [Active metabolites of anti-arrhythmia drugs].
Matusewicz W
Postepy Hig Med Dosw; 1985; 39(2):133-49. PubMed ID: 3900963
[No Abstract] [Full Text] [Related]
8. The clinical pharmacology of antiarrhythmic drugs.
Adams PC; Campbell RW; Julian DG
Cardiovasc Clin; 1984; 14(3):153-90. PubMed ID: 6722851
[No Abstract] [Full Text] [Related]
9. [Therapy control in cardiology: serum level monitoring].
Ochs HR
Z Kardiol; 1984 Oct; 73(10):605-12. PubMed ID: 6516513
[TBL] [Abstract][Full Text] [Related]
10. [Protocol-guide in clinical experimentation on anti-arrhythmia agents].
Tavazzi L; Sanna GP; Tognoni G; Rizzon P
G Ital Cardiol; 1985 Jul; 15(7):711-7. PubMed ID: 4076706
[No Abstract] [Full Text] [Related]
11. [Polycentric clinical experimentation with a new anti-arrhythmia agent: bunaftide].
Botti G
Boll Soc Ital Cardiol; 1972; 17(11):1089-104. PubMed ID: 4620064
[No Abstract] [Full Text] [Related]
12. [Methodological critiques of protocols of clinical studies of anti-arrhythmia agents].
Boissel JP; Leizorovicz A; Peyrieux JC; Alamzecery Y
Arch Mal Coeur Vaiss; 1981 Dec; 74 Spec No():91-6. PubMed ID: 6803707
[No Abstract] [Full Text] [Related]
13. New concepts for antiarrhythmic drugs in the 1980's.
Harrison DC; Irwin WG
Arch Mal Coeur Vaiss; 1981 Dec; 74 Spec No():73-7. PubMed ID: 6803704
[TBL] [Abstract][Full Text] [Related]
14. [Relation between pharmacodynamics and the pharmacokinetics of anti-arrhythmia agents].
Gneushev ET; Starodubtsev AK; Kurapov AP; Kukes VG; Zisel'man SB
Farmakol Toksikol; 1982; 45(3):107-10. PubMed ID: 7095120
[No Abstract] [Full Text] [Related]
15. [Anti-arrhythmia activity and side effects of various anti-arrhythmia agents].
Storozhuk BG
Vrach Delo; 1985 Mar; (3):41-4. PubMed ID: 3892899
[No Abstract] [Full Text] [Related]
16. [Dose finding for clinical trials of antiarrhythmic substances (author's transl)].
Hahn KJ
Arzneimittelforschung; 1977 Feb; 27(2A):283-5. PubMed ID: 577177
[TBL] [Abstract][Full Text] [Related]
17. [Methods for evaluating anti-arrhythmia drugs in man].
Lekieffre J; Libersa C; Caron J; Kacet S; Marchand X
Rev Prat; 1986 Nov; 36(53):3115-8, 3121-9. PubMed ID: 3809930
[No Abstract] [Full Text] [Related]
18. [Pharmacologic treatment of ventricular arrhythmias. General considerations and methods for evaluating its effectiveness].
Iturralde P; Bayés de Luna A; Guindo J
Arch Inst Cardiol Mex; 1987; 57(1):73-6. PubMed ID: 2952094
[No Abstract] [Full Text] [Related]
19. [Antiarrhythmic drugs--differences between laboratory and clinical effects].
Harumi K
Kokyu To Junkan; 1984 Dec; 32(12):1225-33. PubMed ID: 6396782
[No Abstract] [Full Text] [Related]
20. Drugs for cardiac arrhythmias.
Treat Guidel Med Lett; 2004 Nov; 2(27):75-82. PubMed ID: 15529117
[No Abstract] [Full Text] [Related]
[Next] [New Search]
